Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

INTERMOLECULAR INC (IMI) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/20/2019 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Intermolecular, Inc",
"Amended and Restated Bylaws of Intermolecular, Inc"
08/08/2019 8-K Quarterly results
Docs: "Intermolecular Reports Second Quarter 2019 Financial Results"
07/17/2019 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Intermolecular Stockholders Approve Merck KGaA, Darmstadt, Germany's Proposed Acquisition of Intermolecular"
05/14/2019 8-K Quarterly results
Docs: "Intermolecular Reports First Quarter 2019 Financial Results"
05/06/2019 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 6, 2019 Intermolecular, Inc. Delaware 001-35348 20-1616267 3011 N. First Street San Jose, California 95134 Registrant's telephone number, including area code: 582-5700 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement comm...",
"Agreement and Plan of Merger, by and among EMD Group Holding II, Inc., EMD Performance Material Semiconductor Services Corp. and Intermolecular, Inc",
"Form of Support Agreement, by and between EMD Group Holding II, Inc. and certain stockholders of Intermolecular, Inc",
"Intermolecular to be acquired by Merck KGaA, Darmstadt, Germany for $1.20 per share in an all cash transaction • Acquisition to strengthen technology offering and diversify performance materials portfolio of Merck KGaA, Darmstadt, Germany • Transaction expected to close in the second half of 2019 San Jose, California, May 6, 2019 - Intermolecular, Inc. has signed a definitive agreement pursuant to which a wholly owned subsidiary of Merck KGaA, Darmstadt, Germany, a leading science and technology company, will acquire Intermolecular for $1.20 per share in an all cash transaction, representing an equity value of Intermolecular of approximately $62 million. The acquisition has been unanimously approved by Intermolecular's Board of Directors and the Executive Board of Merck KGaA, Darmstadt, Ge...",
"Letter to Intermolecular employees",
"Letter to Intermolecular customers"
02/12/2019 8-K Quarterly results
12/28/2018 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
08/06/2018 8-K Quarterly results
Docs: "Intermolecular Reports Second Quarter 2018 Financial Results Program Revenue Up 45% Year-over-Year, Driving Net Income of $0.5 million and 19% Adjusted EBITDA Margin"
05/25/2018 8-K Submission of Matters to a Vote of Security Holders
05/11/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/08/2018 8-K Quarterly results
Docs: "Intermolecular Reports First Quarter 2018 Financial Results Company Achieves Third Consecutive Quarter of Positive Adjusted EBITDA"
02/13/2018 8-K Quarterly results
Docs: "Intermolecular, Inc. Condensed Consolidated Statements of Operations Three Months Ended December 31, Twelve Months Ended December 31, 2017 2016 2017 2016"
02/12/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/02/2017 8-K Quarterly results
Docs: "Intermolecular Announces Third Quarter 2017 Financial Results SAN JOSE, Calif., November 2, 2017"
11/02/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/10/2017 8-K Quarterly results
09/05/2017 8-K Quarterly results
08/08/2017 8-K Quarterly results
Docs: "Intermolecular Announces Second Quarter 2017 Financial Results SAN JOSE, Calif., August 8, 2017"
05/17/2017 8-K Form 8-K - Current report
05/04/2017 8-K Form 8-K - Current report
05/04/2017 8-K Form 8-K - Current report
04/11/2017 8-K Form 8-K - Current report
03/29/2017 8-K Form 8-K - Current report
03/01/2017 8-K Form 8-K - Current report
02/09/2017 8-K Form 8-K - Current report
12/22/2016 8-K Form 8-K - Current report
11/16/2016 8-K Form 8-K - Current report
11/02/2016 8-K Form 8-K - Current report
09/22/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/04/2016 8-K Quarterly results
Docs: "Intermolecular Announces Second Quarter 2016 Financial Results",
"Intermolecular Appoints Chris Kramer President and CEO"
05/27/2016 8-K Submission of Matters to a Vote of Security Holders
04/01/2016 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter to Securities and Exchange Commission from KPMG LLP"
10/24/2013 8-K Quarterly results
Docs: "EXHIBIT"
10/22/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy